RecruitingPHASE1, PHASE2NCT04711200
LYell SYndrome MEsenchymal Stromal Cells Treatment
Studying Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Saskia Oro, PhDsaskia.oro@aphp.fr
- Intervention
- Adipose derived stromal cells intravenously injected(drug)
- Enrollment
- 15 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- Henri Mondor, Créteil, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04711200 on ClinicalTrials.gov